SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,656.09 286.98
( 0.37%)

Global Indices

Nasdaq

53,439.07 141.06
(0.26%)

Dow Jones

7,673.94 -21.43
(-0.28%)

Hang Seng

65,802.43 274.34
(0.42%)

Nikkei 225

10,857.89 41.33
(0.38%)

Forex

USD-INR

95.63 -0.04
(-0.04%)

EUR-INR

111.66 -0.10
(-0.09%)

GBP-INR

130.46 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

337.9869392

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

44.35

44672.85

EPS(TTM)

Face Value()

Div & Yield %

80.61

0.79

Back

Suratwwala Business Group consolidated net profit rises 75.23% in the June 2026 quarter

Aug 14,2026

Net profit of Suratwwala Business Group rose 75.23% to Rs 9.34 crore in the quarter ended June 2026 as against Rs 5.33 crore during the previous quarter ended June 2025. Sales rose 164.08% to Rs 42.12 crore in the quarter ended June 2026 as against Rs 15.95 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	42.12	15.95	164
OPM %	31.89	43.82	-
PBDT	13.31	7.55	76
PBT	12.66	7.17	77
NP	9.34	5.33	75

77,656.09 286.98 ( 0.37%)

53,439.07 141.06 (0.26%)

7,673.94 -21.43 (-0.28%)

65,802.43 274.34 (0.42%)

10,857.89 41.33 (0.38%)

95.63 -0.04 (-0.04%)

111.66 -0.10 (-0.09%)

130.46 0.10 (0.08%)

0.60 0.00 (-0.21%)